Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (2): 153-154.DOI: 10.3969/j.issn.1673-8640.2016.02.018
• Orginal Article • Previous Articles
Received:2015-01-22
Online:2016-02-20
Published:2016-04-07
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2016.02.018
| 1 | 1.VARDIMAN JW, THIELE J, ARBER DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes[J].Blood,2009,114(5):937-951. |
| 2 | 2.GEORGIN-LAVIALLE S,LHERMITTE L,DUBREUIL P,et al.Mast cell leukemia[J].Blood,2013,121(8):1285-1295. |
| 3 | 3.贾菲. 血液病理学[M]. 陈刚,李小秋,译. 北京:北京科学技术出版社,2013:867-886. |
| 4 | 4.HORNY HP, AKIN C, METCALFE DD, et al. WHO classification of tumours of haematopoietic and lymphoid tissues[M]. Lyon: IARC Press,2008:53-63. |
| 5 | 5.VALENT P, HORNY HP, ESCRIBANO L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal[J]. Leuk Res,2001,25(7):603-625. |
| 6 | 6.VALENT P, AKIN C, SPERR WR, et al. Diagnosis and treatment of systemic mastocytosis: state of the art[J]. Br J Haematol,2003,122(5):695-717. |
| 7 | 7.王建中. 临床检验诊断学图谱[M]. 北京:人民卫生出版社,2012:88. |
| 8 | 8.VALENT P,SOTLAR K,SPERR WR,et al. Refined diagnostic criteria and classification of mast cell leukemia(MCL)and myelomastocytic leukemia(MML):a consensus proposal[J]. Ann Oncol,2014,25(9):1691-1700. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
